Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) FCF Margin (2019 - 2025)

AVITA Medical filings provide 7 years of FCF Margin readings, the most recent being 4.78% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 3838.0% to 4.78% in Q4 2025 year-over-year; TTM through Dec 2025 was 21.8%, a 5516.0% increase, with the full-year FY2025 number at 44.91%, up 3187.0% from a year prior.
  • FCF Margin hit 4.78% in Q4 2025 for AVITA Medical, up from 39.44% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 4.78% in Q4 2025 to a low of 198.23% in Q1 2024.
  • Median FCF Margin over the past 5 years was 62.33% (2023), compared with a mean of 71.45%.
  • Biggest five-year swings in FCF Margin: surged 14432bps in 2021 and later plummeted -10953bps in 2024.
  • AVITA Medical's FCF Margin stood at 9.1% in 2021, then crashed by -259bps to 32.65% in 2022, then plummeted by -132bps to 75.77% in 2023, then skyrocketed by 43bps to 43.16% in 2024, then skyrocketed by 89bps to 4.78% in 2025.
  • The last three reported values for FCF Margin were 4.78% (Q4 2025), 39.44% (Q3 2025), and 55.26% (Q2 2025) per Business Quant data.